Normalizing dysfunctional purine metabolism accelerates diabetic wound healing

Wound Repair and Regeneration

Volumn 23, Issue 1, 2015, Pages 14-21

  Weinstein, Andrew L ^a   Lalezarzadeh, Frank D ^a   Soares, Marc A ^a   Saadeh, Pierre B ^a   Ceradini, Daniel J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; XANTHINE DEHYDROGENASE SMALL INTERFERING RNA; XANTHINE OXIDASE; PURINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC WOUND HEALING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURINE METABOLISM; WILD TYPE; WOUND HEALING; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL LINE; DRUG EFFECTS; GENE EXPRESSION; HOMEOSTASIS; METABOLISM; NONOBESE DIABETIC MOUSE; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CELLS, CULTURED; ENZYME INHIBITORS; GENE EXPRESSION; HOMEOSTASIS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; NIH 3T3 CELLS; OXIDATIVE STRESS; PURINES; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; WOUND HEALING; XANTHINE OXIDASE;

EID: 84928589451     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12249     Document Type: Article

References (42)

1. Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009; 17: 763-771.
2. Brownlee M,. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
3. Ceradini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, Brownlee M, et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 2008; 283: 10930-10938.
4. Agarwal A, Banerjee A, Banerjee UC,. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling. Crit Rev Biotechnol 2011; 31: 264-280.
5. Desco MC, Asensi M, Márquez R, Martínez-Valls J, Vento M, Pallardõ FV, et al. Xanthine oxidase is involved in free radical production in type 1 diabetes. Diabetes 2002; 51: 1118-1124.
6. Inkster ME, Cotter MA, Cameron NE,. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Eur J Pharmacol 2007; 561: 63-71.
7. Niedowicz DM, Daleke DL,. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43: 289-330.
8. Butler R, Morris AD, Belch JJF, Hill A, Struthers AD,. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746-751.
9. Galiano RD, Michaels J 5th, Dobryansky M, Levine JP, Gurtner GC,. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004; 12: 485-492.
10. Thanik VD, Greives MR, Lerman OZ, Seiser N, Dec W, Chang CC, et al. Topical matrix-based siRNA silences local gene expression in a murine wound model. Gene Ther 2007; 14: 1305-1308.
11. Nguyen PD, Tutela JP, Thanik VD, Knobel D, Allen RJ Jr, Chang CC, et al. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators. Wound Repair Regen 2010; 18: 553-559.
12. Kazis LE, Anderson JJ, Meenan RF,. Effect sizes for interpreting changes in health status. Med Care 1989; 27: S178-189.
13. Centers for Disease Control and Prevention. 2011 National Diabetes Fact Sheet. 2011. Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf (accessed March 14, 2013).
14. White R, McIntosh C,. A review of the literature on topical therapies for diabetic foot ulcers. Part 2: advanced treatments. J Wound Care 2009; 18: 335-341.
15. DiPietro LA, Polverini PI, Rahbe SM, Kovacs EJ,. Modulation of JE/MCP-l expression in dermal wound repair. Am J Pathol 1993; 146: 868-875.
16. Engeihardt E, Toksoy A, Goebeler M, Debus S, Bröcker EB, Gillitzer R,. Chemokines IL-8, GROalpha, MGP-t, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998; 153: 1849-1860.
17. Ochoa O, Torres FM, Shireman PK,. Chemokines and diabetic wound healing. Vascular 2007; 15: 350-355.
18. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001; 159: 513-525.
19. Wierusz-Wysocka B, Wysocki H, Wykretowicz A, Szczepanik A, Siekierka H,. Phagocytosis, bactericidal capacity, and superoxide anion production by polymorphonuclear neutrophils from patients with diabetes mellitus. Folia Haematol Int Mag Klin Morphol Blutforsch 1985; 112: 658-668.
20. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H,. Infection and diabetes: the case for glucose control. Am J Med 1982; 72: 439-450.
21. Wetzler C, Kämpfer H, Stallmeyer B, Pfeilschifter J, Frank S,. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115: 245-253.
22. Dupont GP, Huecksteadt TP, Marshall BC, Ryan US, Michael JR, Hoidal JR,. Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest 1992; 89: 197-202.
23. Feve B, Bastard J,. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2009; 5: 305-311.
24. Harrison R,. Structure and function of xanthine oxidase: where are we now? Free Radic Biol Med 2002; 33: 774-797.
25. Pfeffer KD, Huecksteadt TP, Hoidal JR,. Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation. J Immunol 1994; 153: 1789-1797.
26. Romagnoli M, Gomez-Cabrera MC, Perrelli MG, Biasi F, Pallardõ FV, Sastre J, et al. Xanthine oxidase-induced oxidative stress causes activation of NF-κB and inflammation in the liver of type I diabetic rats. Free Radic Biol Med 2010; 49: 171-177.
27. Terada LS, Piermattei D, Shibao GN, McManaman JL, Wright RM,. Hypoxia regulates xanthine dehydrogenase activity at pre- and post-translational levels. Arch Biochem Biophys 1997; 348: 163-168.
28. Rajesh M, Mukhopadhyay P, Batkai S, Mukhopadhyay B, Patel V, Hasko G, et al. Xanthine oxidase inhibitor allopurinol attenuated the development of diabetic cardiomyopathy. J Cell Mol Med 2009; 13 (8B): 2330-2341.
29. Matsumoto S, Koshiishi I, Inoguchi T, Nawata H, Utsumi H,. Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic Res 2003; 37: 767-772.
30. Pritsos CA,. Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem Biol Interact 2000; 129: 195-208.
31. Meneshian A, Bulkley GB,. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 2002; 9: 161-175.
32. Eisenbud DE,. Oxygen in wound healing: nutrient, antibiotic signaling molecule, and therapeutic agent. Clin Plast Surg 2012; 39: 293-310.
33. Hunt TK,. Oxygen and skin wound healing. In:, Rovee DT, Maibach HI, editors. The epidermis in wound healing. Boca Raton, FL: CRC Press, 2004: 183-197.
34. Fries RB, Wallace WA, Roy S,. Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat Res 2005; 579: 172-181.
35. Rees R, Smith D, Li TD, Cashmer B, Garner W, Punch J, et al. The role of xanthine oxidase and xanthine dehydrogenase in skin ischemia. J Surg Res 1994; 56: 162-167.
36. Im MJ, Manson PN, Bulkley GB, Hoopes JE,. Effects of superoxide dismutase and allopurinol on the survival of acute island skin flaps. Ann Surg 1985; 201: 357-359.
37. Kayyali US, Donaldson C, Huang H, Abdelnour R, Hassoun PM,. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J Biol Chem 2001; 276: 14359-14365.
38. Griguer CE,. Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells. Cancer Res 2006; 66: 2257-2263.
39. Ikeda E,. Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int 2005; 55: 603-610.
40. Mole DR, Maxwell PH, Pugh CW, Ratcliffe PJ,. Regulation of HIF by the von Hippel-Lindau tumor suppressor: implications for cellular oxygen sensing. IUBMB Life 2001; 52: 43-47.
41. Tepper OM, Carr J, Allen RJ Jr, Chang CC, Lin CD, Tanaka R, et al. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1 alpha mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 2010; 59: 1974-1983.
42. Moriwaki Y, Yamamoto T, Higashino K,. Enzymes involved in purine metabolism-a review of histochemical localization and functional implications. Histol Histopathol 1999; 14: 1321-1340.